. 2024 Nov 12;44(6):1194–1203. doi: 10.19852/j.cnki.jtcm.2024.06.008

Table 1.

Changes in venous blood glucose levels in rats ( $\bar{x} \pm s$ , mmol/L)

Time point	Normal group (n = 5)	Model group (n = 5)	ZYP group (n = 5)	rhEGF group (n = 5)	SSD group (n = 5)
Before injection of STZ	6.59±0.35	6.78±0.44	6.72±0.43	6.70±0.48	6.64±0.60
Day 7 after STZ injection	6.17±0.40	29.72±3.30^a	30.44±2.66^a	28.20±1.78^a	29.78±3.34^a
Day 14 after STZ injection	6.28±0.23	31.94±1.38^a	32.90±0.46^a	30.04±2.86^a	29.30±3.87^a
Day 7 after treatment	6.21±0.41	30.28±3.44^a	27.32±2.70^a	28.40±3.19^a	28.94±3.47^a
Day 14 after treatment	6.26±0.31	30.02±2.62^a	24.68±2.06^ab	27.20±3.16^a	28.78±3.82^a

Notes: Normal group: normal rats with skin ulcer; Model group: non-intervention group after the establishment of diabetic ulcer model; ZYP group: after modelling diabetic ulcer, treatment with ZYP formula; rhEGF group: after modelling diabetic ulcer, treatment with epidermal growth factor; SSD group: after modelling diabetic ulcer, treatment with 1% sulfadiazine silver cream. ZYP: Zuyangping; rhEGF: epidermal growth factor; SSD: 1% sulfadiazine silver cream. ^aP < 0.05, compared with the normal control group;^bP < 0.05, compared with the model group. All the treated groups were compared with the model group using the Dunnett’s test. Student’s t-test was used to compare differences between the normal and model groups.